Fact-checked by Grok 2 weeks ago

Crystal violet


Crystal violet, also known as gentian violet, is a synthetic organic chloride salt with the molecular formula C_{25}H_{30}ClN_{3}, characterized by its intense violet coloration and primary use as a biological stain in . It serves as the initial in Gram staining, a technique developed in 1884 that distinguishes , which retain the dye due to their thick cell walls, from that do not. Beyond staining, crystal violet possesses antibacterial, , and properties, enabling its application as a topical for treating infections such as thrush and dermatophytoses.
Originally introduced in 1861 as a component of the textile dye , crystal violet's medical and scientific utility expanded in the late , with leveraging its staining capabilities to advance bacterial classification. Its mechanism involves DNA intercalation, which inhibits microbial replication, though prolonged use has raised concerns regarding potential carcinogenicity in animal studies, prompting regulatory scrutiny in some applications. Despite these issues, it remains a staple in protocols and low-resource medical settings for its efficacy and affordability.

Chemical Properties

Molecular Structure and Synthesis

Crystal violet possesses the molecular formula C_{25}H_{30}ClN_3 and exists as the chloride salt of a triarylmethylium cation. The structure features a central carbon atom sp²-hybridized and bonded to three phenyl rings, each bearing a para-dimethylamino substituent. This configuration enables extensive resonance delocalization of the positive charge across the nitrogen lone pairs and π-systems of the aromatic rings, conferring a planar geometry and intense violet coloration to the compound. The standard synthesis of crystal violet proceeds via condensation of Michler's ketone—4,4'-bis(dimethylamino)benzophenone—with in the presence of phosphorus oxychloride (POCl_3). In this reaction, POCl_3 functions as both a Lewis acid and an oxidant, promoting electrophilic attack by the activated ketone on the aniline, followed by dehydration and aromatization to form the triarylmethane framework. The resulting dye base is then neutralized with to yield the salt, which precipitates from solution. Commercial production adheres closely to this route, leveraging its for large-volume manufacturing, though variants incorporate alternative chlorinating agents or oxidants such as or ferric salts to enhance purity and reduce byproducts like lower-methylated violets. Impurities, including residual Michler's ketone or the colorless leuco (carbinol) form, are minimized through recrystallization from or acidification steps, ensuring the dye meets specifications for spectroscopic consistency. Modern processes prioritize conditions to prevent , with overall yields optimized above 70% in industrial settings.

Physical and Spectroscopic Properties

Crystal violet manifests as a dark green powder or greenish glistening crystals with a metallic luster in its solid form. Upon dissolution in polar solvents such as or , it yields intensely violet solutions, with in reaching approximately 50 g/L at 27°C and in around 100 g/L. The compound exhibits poor in non-polar solvents like (partial) or hydrocarbons, consistent with its ionic salt nature. The characteristic violet coloration stems from a strong UV-Vis absorption band centered at 590 , with a extinction coefficient of 87,000 M⁻¹ cm⁻¹, arising from π-π* electronic transitions within the extended of the resonance-stabilized triarylmethylium . This peak dominates the , rendering the opaque to yellow-green light while transmitting blue- wavelengths. Crystal violet displays pH-dependent spectral shifts; in strongly acidic conditions ( < 2), protonation of the central carbon atom forms a dication, altering the conjugation and shifting the solution color from violet to . Thermally, the compound remains stable below 170–200°C, beyond which occurs without a defined . Photostability is limited, with exposure to visible or UV light inducing degradation primarily through photoreduction to the colorless leuco form or oxidative cleavage of the , leading to fading over time.

Applications

Industrial and Textile Uses

Crystal violet, a synthetic , is employed in the for coloring fabrics, particularly due to its intense violet hue and affinity for binding to natural and synthetic fibers such as and . Its low production cost facilitates widespread use in large-scale processes, where it provides durable coloration under standard conditions. In printing applications, crystal violet serves as an in inks, imparting a bright shade suitable for and other methods, though it exhibits limited resistance to alkalis and soaps, necessitating careful formulation. It is also incorporated into paints for industrial coatings and used in paper manufacturing to achieve deep tones in products like specialty papers. These applications contribute to its annual global production in tons, primarily from dye manufacturers in regions with active sectors. Effluents from dyeing, , and release crystal violet into , resulting in environmental that persists due to its and low biodegradability. Remediation efforts have focused on using agricultural wastes, with studies demonstrating removal efficiencies exceeding 90% under optimized conditions; for instance, chemically modified achieved 98.35% dye uptake at pH 7 and 120 minutes contact time. Other biosorbents, such as water hyacinth powder, have reported up to 93% efficiency in batch processes, highlighting cost-effective strategies for mitigating industrial pollution.

Scientific and Laboratory Applications

Crystal violet functions as the primary stain in Gram staining, a core microbiological technique for distinguishing Gram-positive from Gram-negative bacteria based on cell wall properties. The dye, a basic triarylmethane compound, penetrates and stains all bacterial cells purple initially. After iodine mordant forms a crystal violet-iodine complex and decolorization with alcohol disrupts the outer membrane of Gram-negative cells, the complex remains trapped in the thick peptidoglycan layer of Gram-positive bacteria—comprising up to 90% of their cell wall—resulting in persistent purple coloration under light microscopy, while Gram-negative cells appear pink upon counterstaining with safranin. In cell biology, crystal violet enables quantification of adherent cell viability and proliferation through staining assays. Fixed cells are stained with the dye, which binds electrostatically to cellular proteins and DNA; excess dye is washed away, and bound stain is solubilized in acidic solutions (e.g., 10% acetic acid) for absorbance measurement at 590 nm, where intensity correlates directly with viable cell count, serving as a cost-effective alternative to metabolic assays like MTT. Crystal violet quantifies biofilm formation in research settings via microtiter plate assays. , consisting of microbial communities embedded in extracellular polymeric substances, are fixed, stained with the that adheres to both cells and components, rinsed to remove unbound , and solubilized (often in or ) for optical density reading at 570–620 nm, providing an indirect measure of despite lacking specificity for live versus dead material. The compound also aids spectroscopic and serves as a model cationic in adsorption kinetics studies. Its visible absorbance peak around 590 nm follows Beer's law, enabling concentration determination via UV-Vis , while quantifies it using internal standards like . In environmental research, crystal violet models removal processes, with adsorption onto various sorbents often fitting pseudo-second-order kinetics and Freundlich isotherms.

Medical and Veterinary Applications

Crystal violet, commonly applied as gentian violet in medical contexts, serves as a topical with demonstrated antibacterial and properties, particularly effective against such as (including methicillin-resistant strains) and fungi like . Studies have shown its utility in eradicating methicillin-resistant from decubitus ulcers, with applications achieving bacterial clearance in affected sites. assessments confirm low critical concentrations required for inhibiting , , and species, supporting its role in managing superficial infections. Clinically, gentian violet has been employed for treating oral thrush and nipple candidiasis during , with comparative trials indicating comparable efficacy to nystatin oral suspension in resolving . For wound care, a of 1% gentian violet applied to lower extremity wounds and eschars reported effective healing of small, superficial lesions, positioning it as a low-cost option in resource-limited settings. Its antifungal action extends to dermatological conditions like cutaneous yeast infections, where it aids in active sites, as explored in trials for . However, practical limitations include persistent purple staining of tissues and clothing, which can deter patient compliance despite its affordability. In , crystal violet finds application as an and agent in , treating bacterial, fungal, and protozoal infections in , including ornamental species. It has been used topically for wounds and as an additive in to control , though such practices predate current restrictions. Despite of against ectoparasites and infections in non-food species, its use in food-producing animals is prohibited in regions like the due to residue persistence concerns, limiting deployment to non-edible contexts. Empirical data from residue studies underscore its persistence in tissues, informing regulatory caution while affirming targeted therapeutic value.

Safety, Toxicity, and Regulatory Status

Acute Toxicity and Health Effects

Crystal violet demonstrates moderate acute oral toxicity in , with reported LD50 values of 420 mg/kg in rats and approximately 96 mg/kg in mice. of significant quantities can induce gastrointestinal irritation, including , , , and , as inferred from toxicological profiles in safety data. These effects arise from the compound's irritant properties on mucosal tissues, potentially exacerbated by its cationic dye nature disrupting cellular membranes upon direct contact. Dermal to crystal violet typically results in irritation, manifesting as or redness, though severe burns are uncommon under brief . Ocular poses a higher risk, causing serious eye damage such as , corneal injury, and potential permanent impairment, as documented in guidelines emphasizing immediate flushing. Inhalation of dust or vapors from the solid or concentrated solutions may irritate the , leading to coughing, throat discomfort, or , particularly in poorly ventilated settings. Empirical handling protocols stress including gloves, , and respiratory masks where dust generation occurs, alongside adequate to minimize airborne exposure. Accidental exposures in or industrial contexts have generally resolved with , underscoring the importance of prompt to avert localized irritation without systemic sequelae in most instances.

Carcinogenicity, Genotoxicity, and Long-Term Risks

Crystal violet demonstrates in multiple assays, including positive results in the Ames bacterial reverse test using typhimurium strains, indicating potential for inducing point mutations without metabolic activation. It also exhibits clastogenic effects, disrupting structure, and acts as a mitotic by interfering with spindle assembly during . These properties suggest a capacity for DNA damage, though findings require corroboration from data, as cellular metabolism and repair mechanisms absent in such tests may modulate outcomes. In , of crystal violet at high doses (e.g., 100 mg/kg body weight daily) to rats induced tumors, liver hepatocellular adenomas, and tumors, providing sufficient evidence of carcinogenicity in per International Agency for Research on Cancer (IARC) evaluations. Repeated ingestion in rats and mice also produced gastric papillomas and hepatic , with tumor promotion observed in models where it enhanced lesion development at concentrations as low as 1-10 mg/L. These effects occur via mechanisms including and disruption of mitotic checkpoints, lacking a clear no-effect due to its potency as a promoter even at sub-mutagenic levels. Epidemiological data in humans remain limited and inconclusive, with no confirmed excess cancer incidence linked to occupational or therapeutic exposures despite decades of use in and ; IARC thus classifies it as possibly carcinogenic (Group 2B) based primarily on animal evidence rather than direct human risk. This precautionary stance contrasts with historical applications showing minimal reported long-term oncogenic effects, underscoring the need to weigh empirical animal potency against absent human causal links in assessing real-world risks.

Regulatory Actions and Bans

In the United States, the (FDA) has prohibited the use of crystal violet (gentian violet) as a veterinary in food-producing animals, including species, under regulations such as 21 CFR 500.29 and 21 CFR 500.30, due to concerns over residues and potential carcinogenicity. This restriction, enforced since the through extralabel use prohibitions and feed additive bans (21 CFR 589.1000), has led to import refusals for contaminated , such as and detected with crystal violet residues as recently as 2025. In the , crystal violet is unauthorized for use in food-producing animals, with zero-tolerance residue limits applied to imported products like and , resulting in bans on contaminated shipments since at least 2010. California lists crystal violet under Proposition 65 as a chemical known to cause cancer, added on November 23, 2018, based on animal carcinogenicity data, requiring warnings for exposures above specified levels. Similar veterinary prohibitions exist in , , , and the , where gentian violet is barred from food animal use, with issuing a 2019 alert to discontinue all human and veterinary products containing it due to potential cancer risks from . Despite these restrictions in developed regions, crystal violet remains approved or tolerated for limited medical and veterinary applications in some developing countries, particularly for treatment in low-resource settings where alternatives are scarce. Regulatory reviews in the , such as Singapore's Health Sciences Authority assessment in May 2020, concluded that human carcinogenicity evidence is insufficient—primarily derived from high-dose animal exposures—and recommended restricting use to short-term external applications rather than imposing total bans, highlighting a precautionary approach in stricter jurisdictions versus evidence-based risk evaluations elsewhere. These discrepancies have sparked debate over whether blanket prohibitions overlook the compound's utility in resource-limited contexts, with advocates for risk-based assessments arguing that low-exposure human data do not justify universal restrictions given the lack of confirmed epidemiological links to cancer.

History

Discovery and Early Synthesis

Crystal violet, chemically hexamethyl pararosaniline chloride and also known as methyl violet 10B, emerged during the rapid expansion of synthetic aniline dyes following William Henry Perkin's of in 1856, which catalyzed the industrial production of coal-tar derived colorants. This boom led to the development of triarylmethane dyes, including violet variants, as chemists explored of rosaniline bases to achieve brighter, more stable hues for textiles. The initial synthesis of methyl violet, from which crystal violet derives as the principal hexamethylated component, is attributed to French chemist Charles Lauth in 1861, who produced it via exhaustive methylation of pararosaniline using methyl iodide or similar agents, yielding a violet dye initially marketed as "Violet de Paris." Early preparations were mixtures of polymethylated rosanilines, with crystal violet representing the fully hexamethylated form valued for its intense color and solubility. Industrial optimization occurred in the 1880s amid efforts to scale production safely and efficiently. In 1883, German chemist Alfred Kern developed a -based route involving condensation of with to form Michler's ketone, followed by reaction with more and oxidation, but the hazardous process prompted collaboration with Heinrich Caro at for refinement. Caro, a pioneer in and synthesis, adapted empirical purification techniques to isolate purer crystal violet, enabling 's patenting and commercial rollout by 1884 as a stable, brilliant dye superior to earlier violets in fastness to light and washing. This method marked a key advancement in synthesis, prioritizing yield and consistency over the variable of prior routes.

Development and Naming as Gentian Violet

Crystal violet, synthesized in the mid-19th century and initially marketed as or violet, acquired the name "gentian violet" around 1880 through the efforts of German pharmacist Georg Grübler, who sought to evoke the violet pigmentation of natural gentian root dyes for commercial appeal, notwithstanding its entirely synthetic triarylmethane structure. This rebranding aligned with its emerging utility in biological staining, distinguishing it from earlier textile dyes and positioning it as a reagent reminiscent of botanical extracts used in . Early microbiological applications leveraged gentian violet's affinity for cellular structures; for instance, in studies of pathogens like the (), researchers including Albert Neisser employed it alongside fuchsin stains in the late and early to enhance visualization in tissues, predating its routine use in diagnostics which favored acid-fast methods. The dye's adoption accelerated in 1884 when Danish bacteriologist developed a protocol using aniline-gentian (crystal violet) mordanted with iodine, followed by alcohol decolorization and counterstaining; this method retained the violet dye in —appearing purple—while gram-negative types decolorized to pink, enabling rapid bacterial classification based on differences. Gram's technique, published in 1884, established gentian violet's foundational role in , supplanting less reliable prior stains and facilitating etiological identifications in clinical samples. Into the early , pharmaceutical refinements emphasized stable aqueous formulations of gentian violet at concentrations of 1-2% for topical antiseptics, optimizing and for care and mucosal infections while minimizing issues in alcoholic preparations. These solutions exploited the compound's selective bactericidal action against gram-positive organisms, as quantified in studies by Churchman demonstrating inhibition zones proportional to concentration, paving the way for its broad deployment in treating conditions like and thrush before antibiotics dominated.

Evolution of Uses and Emerging Controversies

During the mid-20th century, gentian violet experienced expanded veterinary applications, particularly as an agent in feed to combat mold in and prevent infections amid antibiotic limitations during and post-World War II shortages. Its use surged for treating bacterial and fungal conditions in animals, reflecting its low cost and broad antimicrobial spectrum, though lacking formal approval as a new animal drug. By the 1970s, however, accumulating toxicity data shifted perceptions, with U.S. (FDA) scrutiny targeting unapproved marketing by feed additive firms; a 1977 (GAO) report affirmed the reasonableness of FDA's enforcement actions, citing unresolved safety questions from preliminary rodent studies indicating potential chronic risks. Subsequent 1980s investigations, including chronic feeding trials in mice and rats, demonstrated carcinogenicity at multiple organ sites and genotoxic effects, prompting further restrictions on its use in food-producing animals. In the , gentian violet has seen a resurgence in dermatological and alternative medical contexts, driven by research uncovering anti-angiogenic mechanisms that inhibit and angiopoietin-2, potentially aiding , eczema reduction, and antitumor effects in skin conditions like . Studies from 2013 onward highlight its efficacy against bacterial colonization and inflammation in resource-limited settings, positioning it as a viable option for topical infections where modern antibiotics face resistance. Yet, this revival coincides with heightened safety warnings, particularly for pediatric applications; reviews between 2013 and 2020, including Health Canada's 2019 alert, emphasized and potential carcinogenicity based on animal data, advising against routine use for infant oral thrush due to risks of mucosal , , and systemic in vulnerable populations. The ongoing discourse balances gentian violet's empirically demonstrated utility—supported by over a century of clinical observations in empiric-poor environments against sparse alternatives—with findings from and models that classify it as a possible carcinogen ().00178-9/abstract) Despite these concerns, no definitive epidemiological link to cancers has emerged after extensive historical exposure, with proponents arguing that low-dose topical applications pose negligible risk compared to benefits in underserved areas, while regulators prioritize precautionary bans in veterinary and consumer products.00388-0/fulltext) This tension underscores causal uncertainties: while animal carcinogenicity drives restrictions, the absence of tumor induction suggests species-specific or thresholds may limit translatability.

References

  1. [1]
    Crystal Violet | C25H30ClN3 | CID 11057 - PubChem
    Crystal violet is an organic chloride salt that is the monochloride salt of crystal violet cation. It has been used in creams for the topical treatment of ...Leucocrystal Violet
  2. [2]
    Hans Christian Joachim Gram | Danish bacteriologist - Britannica
    In 1884 the Danish microbiologist Hans Christian Gram discovered that crystal violet irreversibly stains certain bacteria but can be washed from others.
  3. [3]
    Gentian Violet: Uses, Interactions, Mechanism of Action - DrugBank
    Gentian Violet is an antiseptic violet dye used to prevent various infections, including fungal and bacterial infections.
  4. [4]
    Diagnostic Dyes - Viewing the Invisible - Glentham Life Sciences
    Apr 12, 2025 · Crystal violet is a synthetic triarylmethane dye first introduced in 1861 as one of the components of the textile dye methyl violet. Soon after ...Crystal Violet · Methylene Blue · Haematoxylin
  5. [5]
    Gentian Violet: A 19th Century Drug Re-Emerges in the 21st Century
    GV was first introduced as an antiseptic by Stilling in 1891, which he marketed as pyoctanin. Stilling made boisterous claims about pyoctanin's therapeutic use ...Antibacterial Activity · Anti-Angiogenesis And... · Dermatitis And Other Uses In...
  6. [6]
    Crystal Violet | 548-62-9 - ChemicalBook
    Sep 25, 2025 · Crystal Violet ; Molecular Formula: C25H30ClN3 ; Molecular Weight: 407.99 ; MDL Number: MFCD00011750 ; MOL File: 548-62-9.mol ; MSDS File: SDS.
  7. [7]
    Gentian Violet | Crystal Violet | Properties, Uses and Side Effects
    Gentian Violet, also known as Crystal Violet, is a primary dye used for Gram staining, as an antibacterial, antifungal, and antihelminthic agent.
  8. [8]
    Crystal Violet | ACS Reagent Chemicals - ACS Publications
    Feb 28, 2017 · CAS No. 548-62-9 ; Typical appearance. dark green powder or greenish glistening pieces with metallic luster ; Applications. indicator for copper ...Missing: properties | Show results with:properties
  9. [9]
  10. [10]
    Crystal Violet - PhotochemCAD
    PhotochemCAD ID, L03. Compound Category, Arylmethane Dyes. Name, Crystal Violet ; Absorption Wavelength, 590.5. Absorption Epsilon, 75800. Absorption Coefficient ...
  11. [11]
    [PDF] Adsorption Equilibrium and Kinetics of Crystal Violet Dye from ...
    The absorption behavior of CV dye was performed by taking known concentration of dye. The pH range used for the study was from 1 to 10. The pH of the dye ...
  12. [12]
    CRYSTAL VIOLET For Microscopy - Alpha Chemika
    Physical Properties. Solubility in water(% weight), Soluble in water. Colour, Dark green powder. Melting point/ Freezing point(°C), 173 °C. Odour, Slight ...
  13. [13]
    Comparing different light-degradation approaches for the ...
    The current research focusses on the photodegradation of crystal violet (CV) and eosin Y (EY) as model components, both with a poor light fastness (ISO 2 and ...Missing: thermal | Show results with:thermal
  14. [14]
    Enhanced removal of crystal violet using rawfava bean peels, its ...
    Crystal violet is a basic dye that is widely used by various industries, such as textiles and paints. These industries discharge their effluents, contaminated ...
  15. [15]
    What is Crystal Violet? Uses, How It Works & Top Companies (2025)
    Oct 10, 2025 · Textile producers use Crystal Violet to dye fabrics, giving textiles their vibrant purple color. Its ability to bind well with fibers like ...
  16. [16]
    Crystal Violet - PrintWiki
    An organic color pigment used in printing inks. Crystal Violet is a bright violet with good color qualities, but poor resistance to alkalis and soaps.Missing: paper | Show results with:paper
  17. [17]
    Crystal violet – Knowledge and References - Taylor & Francis
    Crystal violet is a synthetic, cationic dye used in industries like textile, paper, and printing, and as a staining solution and antiseptic. It is also known ...
  18. [18]
    [PDF] Experimental study on Solvent Extraction of Crystal Violet dye-IJAERD
    It imparts deep violet colour in paints and printing inks. It is also used to obtain shades of deep colours that can be applied for the dyeing of cotton, silk,.
  19. [19]
    Adsorption of crystal violet dye from synthetic wastewater by ball ...
    Mar 4, 2024 · A triphenylmethane dye called crystal violet (CV) has been widely utilized as a biological stain in human and veterinary medicine, as a textile ...
  20. [20]
    Innovative Biosorption of Crystal Violet Dye Using Chemically ...
    Jul 2, 2025 · The results revealed that CPCL exhibited better adsorption capacity, achieving a maximum dye removal efficiency of 98.35%, compared to 97.02% ...<|control11|><|separator|>
  21. [21]
    Adsorptive Optimization of Crystal Violet Dye Using Central ...
    Nov 17, 2022 · In this work, water hyacinth (Eichhornia crassipes) powder was used as an efficient adsorbent for the removal of crystal violet from aqueous solutions.
  22. [22]
    Gram Staining - StatPearls - NCBI Bookshelf
    Mar 28, 2025 · The first step in Gram staining is using crystal violet dye for the slide's initial staining. The next step, also known as fixing the dye ...
  23. [23]
    1.10: Gram Stain - Biology LibreTexts
    Feb 17, 2023 · The crystal violet is not removed from the Gram-positive cells since the iodine-crystal violet complexes adhere to the thick peptidoglycan layer ...The Gram Stain Shows... · How the Gram Stain Works · Improving and...
  24. [24]
    Gram Stain: What It Is, Purpose, Procedure & Results
    The peptidoglycan forms about 90% of the cell wall in gram-positive bacteria. This causes them to appear blue to purple under a Gram stain.
  25. [25]
    Crystal Violet Assay for Determining Viability of Cultured Cells
    Apr 1, 2016 · One simple method to detect maintained adherence of cells is the staining of attached cells with crystal violet dye, which binds to proteins and DNA.
  26. [26]
  27. [27]
    Quantitative Analyses of Biofilm by Using Crystal Violet Staining and ...
    Sep 28, 2022 · In this method, crystal violet staining [30,31,32] biofilms are extracted into sodium dodecyl sulfate (SDS) solution and the absorbance by 590 ...
  28. [28]
    Microtiter Dish Biofilm Formation Assay - PMC - NIH
    Jan 30, 2011 · In this assay, the extent of biofilm formation is measured using the dye crystal violet (CV). However, a number of other colorimetric and ...Microtiter Dish Biofilm... · Protocol · 1. Growing A Biofilm
  29. [29]
    Quantitative Analysis of Crystal Violet by Raman Spectroscopy
    Mar 1, 2012 · This article describes the application of Raman spectroscopy to quantitatively measure the concentration of crystal violet using acetonitrile as the internal ...
  30. [30]
    Modeling and Optimizing the Crystal Violet Dye Adsorption on ... - NIH
    May 30, 2023 · The Freundlich and pseudo-second-order kinetic models were the best isotherm and kinetic models fitting our results. Furthermore, the study ...
  31. [31]
    Gentian Violet: a 19th century drug re‐emerges in the 21st century
    Oct 7, 2013 · Gentian violet has shown excellent anticandidal efficacy in vitro, with significantly greater antimycotic activity against 91 candidal strains ...
  32. [32]
    Efficacy of gentian violet in the eradication of methicillin ... - PubMed
    The efficacy of gentian violet (Gv) in eradicating methicillin-resistant Staphylococcus aureus (MRSA) in decubitus ulcers was investigated.Missing: uses | Show results with:uses
  33. [33]
    NCT01427738 | Gentian Violet Vs. Nystatin Oral Suspension for ...
    The purpose of this study was to see which one of two medicines (topical gentian violet [GV] or nystatin oral suspension) was better than the other in ...
  34. [34]
    Gentian Violet 1% Solution in the Treatment of Wounds in the ...
    The findings from this study suggest that GV is an effective topical agent for healing small, superficial wounds and pressure ulcer eschars on the lower ...Missing: trials | Show results with:trials
  35. [35]
    Study Details | Gentian Violet Treatment for Hidradenitis Suppurativa
    Gentian violet is a topical antiseptic used to treat many cutaneous yeast infections. It also has a role in improving wound healing in sites of active ...
  36. [36]
    Gentian Violet and Leucogentian Violet - NCBI - NIH
    Gentian violet is used in veterinary medicine and in the aquaculture industry for the control of ectoparasites, and fungal and bacterial infections. Residues of ...
  37. [37]
    [PDF] HRD-80-91 FDA's Regulation of Gentian Violet Appears Reasonable
    Dec 7, 1977 · Gentian violet, a dye, has been used as an animal drug to treat many diseases and as an additive in animal feed to inhibit mold. If drugs or ...Missing: aquaculture | Show results with:aquaculture
  38. [38]
    [PDF] Evidence on the Carcinogenicity of Gentian Violet - OEHHA
    Aug 17, 2018 · The use of gentian violet in animal feed or as a veterinary drug in food animals is prohibited in the US. The US Food and Drug Administration ( ...Missing: livestock | Show results with:livestock<|separator|>
  39. [39]
    Persistence of gentian violet and leucogentian violet in channel ...
    CV is used as a veterinary drug for the antifungal and antiparasitic treatment of ornamental fish, but has multiple other applications such as pH indicator ...Missing: livestock | Show results with:livestock
  40. [40]
  41. [41]
    [PDF] Safety Data Sheet - Fisher Scientific
    Jun 17, 2015 · Acute Toxicity: Oral: 420 mg/kg LD50 orl - rat. Chronic Toxicity: No additional information. Corrosion Irritation: No additional information.
  42. [42]
  43. [43]
    [PDF] Crystal Violet | Safety Data Sheet | Durham Tech
    Sep 3, 2014 · Acute Toxicity: Chemical Name. CAS Number. Oral LD50. Dermal LD50. Inhalation LC50. Crystal Violet. 548-62-9. Oral LD50 Rabbit. 150 mg/kg. Oral ...Missing: rodents | Show results with:rodents
  44. [44]
  45. [45]
    [PDF] SAFETY DATA SHEET Crystal Violet
    Acute toxicity - inhalation. Notes (inhalation LC₅₀). Converted acute toxicity point estimate (cATpE) Toxic if inhaled. ATE inhalation (gases ppm). 700.0. ATE ...<|separator|>
  46. [46]
    Cytogenetic toxicity of gentian violet and crystal ... - ScienceDirect.com
    It is suggested that a human cancer hazard may exist where significant quantities of finished benzidine dye samples are handled. Such risks from exposures ...
  47. [47]
    Liquid–liquid phase reaction between crystal violet and sodium ...
    Oct 12, 2022 · UV-vis spectroscopy was used for quantitative analysis, specifically for the reaction order and rate constant derivation, while video imaging ...
  48. [48]
    [PDF] Evidence on the Carcinogenicity of Gentian Violet - OEHHA
    Of these seven comparison compounds, three are classified by IARC as Group 2B carcinogens. (C.I. Basic Red 9, Michler's ketone, and Magenta), and two of the ...
  49. [49]
    [PDF] Crystal Violet - Santa Cruz Biotechnology
    Prolonged exposure can cause nausea, headache, vomiting and nose bleed. The material may be tumorigenic and mutagenic. Probably all commercial brands of ...
  50. [50]
    IARC Monographs evaluation of the carcinogenicity of gentian violet ...
    Mar 26, 2021 · The Working Group evaluated gentian violet, leucomalachite green, and CI Direct Blue 218 as possibly carcinogenic to humans (Group 2B) mainly on the basis of ...
  51. [51]
    IARC Monographs Volume 129: Gentian Violet, Leucogentian Violet ...
    Mar 10, 2022 · The Working Group concluded that gentian violet, leucomalachite green, and CI Direct Blue 218 are possibly carcinogenic to humans (Group 2B)
  52. [52]
    Carcinogenicity of gentian violet, leucogentian violet, malachite ...
    Mar 25, 2021 · Gentian violet, leucomalachite green, and CI Direct Blue 218 were classified as “possibly carcinogenic to humans” (Group 2B) on the basis of “sufficient” ...
  53. [53]
    FDA's First Antibiotic-Contaminated Shrimp Refusals of 2025 Are of ...
    Mar 5, 2025 · ... Aquaculture Seafood Products Due to Unapproved Drugs”) on February 10, 2025 due to a finding of the banned fungicide Crystal Violet in its ...
  54. [54]
    [PDF] 5. Gentian violet
    Apr 7, 2014 · Gentian violet has been used as an antifungal and antiparasitic agent for treatment of fish, and also as a topical antiseptic, antibacterial and ...
  55. [55]
    [PDF] eu bans imported seafood products contaminated with crystal violet ...
    The new regulation has blocked over 50 percent of Bangladesh shrimp export to EU which used the old maximum residue limit of crystal violet at ...<|separator|>
  56. [56]
    [PDF] January 3, 2025 List of Proposition 65 chemicals - OEHHA
    Jan 3, 2025 · The list is published in Title. 27, California Code of Regulations ... Gentian violet (Crystal violet) cancer. 548-62-9. November 23, 2018.
  57. [57]
    Health Canada warns Canadians of potential cancer risk associated ...
    Stop using all drug products that contain gentian violet, including on animals. Products for humans should be returned to a pharmacy for proper disposal. Animal ...Missing: crystal global
  58. [58]
    Safety update on gentian violet antiseptic - Health Sciences Authority
    May 5, 2020 · The documented therapeutic uses of topical GV-containing products include the treatment of bacterial skin infections and fungal infections.
  59. [59]
    Dye - Synthetic, Organic, Colorants | Britannica
    In 1884 the Danish microbiologist Hans Christian Gram discovered that crystal violet irreversibly stains certain bacteria but can be washed from others. The dye ...
  60. [60]
  61. [61]
    Quirks of dye nomenclature. 7. Gentian violet and other violets
    The name, gentian, appeared about 1880. Immediately following its discovery in 1861, this violet dye was known as Violet de Paris or as methyl violet.
  62. [62]
    Heinrich Caro and the Creation of Modern Chemical Industry
    In 1883, a new episode of the tri-arylmethanes commenced by employing the toxic gas phosgene in dye synthesis, resulting in Crystal violet. To overcome the ...Missing: 1884 | Show results with:1884
  63. [63]
    Quirks of dye nomenclature. 7. Gentian violet and other violets
    Jan 19, 2017 · The name, gentian, appeared about 1880. Immediately following its discovery in 1861, this violet dye was known as Violet de Paris or as methyl ...
  64. [64]
    [PDF] 6 and the so-called hansen-neisser controversy
    They appeared most beautifully with fuchsin and gentian violet stains .... " [They were found] "in astonishing numbers in both fresh and fixed material of ...
  65. [65]
    [PDF] The Directed Steps of Hans Christian Gram - Liberty University
    Jan 19, 2022 · Gram stained his preparations with aniline gentian violet, adding Lugol's iodine solution for one to three minutes. When he then removed the ...
  66. [66]
    Hans Christian Gram - Linda Hall Library
    Sep 13, 2023 · Gram was doing just that in 1884, when he found that bacteria could be stained purple by a compound called crystal violet. If you then washed ...
  67. [67]
    Gentian violet: Revisited - Indian Journal of Dermatology ...
    Jul 30, 2020 · Gentian violet is also effective against Candida. Gentian violet has been tried in lymphoma patients.
  68. [68]
    The Antibacterial Action of Safranin and Gentian Violet - PMC - NIH
    Throughout the first half of the twentieth century, gentian violet was widely adopted for use in a variety of diseases including trench mouth, thrush, impetigo ...
  69. [69]
    Chronic toxicity and carcinogenicity studies of gentian violet in mice
    Under the conditions of the experiment described above, gentian violet appears to be a carcinogen in mice at several different organ sites.Missing: 1970s | Show results with:1970s
  70. [70]
    Chronic toxicity/carcinogenicity studies of gentian violet in fischer ...
    A chronic feeding study was carried out in the F1a generation of dosed Fischer 344 rats of both sexes with gentian violet (GV).Missing: 1970s | Show results with:1970s
  71. [71]
    Gentian Violet Inhibits Cell Proliferation through Induction of ... - NIH
    Jun 7, 2023 · Currently, GV is being studied as a treatment for skin diseases and as an anti-angiogenic and antitumor drug [13,14]. Studies have demonstrated ...
  72. [72]
    Summary Safety Review - Gentian violet-containing human health ...
    There have been no reported cases of cancer in humans associated with the use of topical gentian violet in Canada or internationally.Missing: Singapore HSA 2020
  73. [73]
    Exposure to Crystal Violet, Its Toxic, Genotoxic and Carcinogenic ...
    Crystal Violet (CV), a triphenylmethane dye, has been extensively used in human and veterinary medicine as a biological stain, as a textile dye in textile ...